Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Parkinson’s Disease Drugs
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Oral Route of Administration, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 ... Read More
-
Sterols
... of 5.7% over the analysis period 2023-2030. Beta-Sitosterol, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$921.7 Million by the end of the analysis period. Growth ... Read More
-
Chronic Kidney Disease (CKD) Drugs
... is expected to reach US$19.5 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Antihypertensives, one of the segments analyzed in the report, is expected to record a 4.5% CAGR ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More
-
Europe Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032
... Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032 Europe Next Generation Sequencing Market Outlooks Next ... Read More
-
Manual Filling Equipment
... at a CAGR of 6.6% over the analysis period 2023-2030. Food & Beverages End-Use, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the ... Read More
-
Campesterol
... 8.4% over the analysis period 2023-2030. Food Ingredients Application, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$143.1 Million by the end of the analysis period. ... Read More
-
Hyperlipidemia Drugs
... CAGR of 8.6% over the analysis period 2023-2030. Statins Drug Class, one of the segments analyzed in the report, is expected to record a -6.0% CAGR and reach US$3.5 Billion by the end of the ... Read More
-
Global Pyrrolidine Market Report, History and Forecast 2019-2030
... of 3.18% during 2024-2030. North American market for Pyrrolidine was valued at $ 10.22 million in 2023 and will reach $ 12.02 million by 2030, at a CAGR of 2.15% during the forecast period of ... Read More
-
Anti-Allergy Drugs
... at a CAGR of 7.1% over the analysis period 2023-2030. Pharmacies Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$35.4 Billion by the end of ... Read More
-
Sterile Medical Packaging
... by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Plastics Material, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$36.5 Billion by ... Read More
-
Superdisintegrants
... of 5.3% over the analysis period 2023-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$262.2 Million by the end of the analysis period. ... Read More
-
Tangential Flow Filtration
... by 2030, growing at a CAGR of 12.0% over the analysis period 2023-2030. Single-Use Systems, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.0 Billion by ... Read More
-
Sterility Testing
... at a CAGR of 10.8% over the analysis period 2023-2030. Sterility Testing Kits & Reagents, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$184.9 Million by ... Read More
-
Healthcare Analytical Testing Services
... reach US$11.7 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and ... Read More
-
Healthcare Cold Chain Logistics
... reach US$23.8 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$11.1 ... Read More
-
Medical Packaging
... at a CAGR of 5.5% over the analysis period 2023-2030. Medical Tools & Equipment Application, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$27.0 Billion by ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
United States Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032
... Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032 United States Next Generation Sequencing Market Size ... Read More
-
Semi-Automatic Filling Equipment
... at a CAGR of 6.4% over the analysis period 2023-2030. Food & Beverages End-Use, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.0 Billion by the ... Read More
-
Beta-Sitosterol
... 8.0% over the analysis period 2023-2030. Food Ingredients Application, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$510.6 Million by the end of the analysis period. ... Read More
-
Portugal Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Portugal) report will tell you the companies that have a declining financial ... Read More
-
India Pharmaceuticals and Medicine - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals and Medicine (India) report will tell you the ... Read More
-
Belgium Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Belgium) report will tell you the companies that have a declining financial ... Read More
-
Heart Failure Drugs
... by 2030, growing at a CAGR of 12.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 16.2% CAGR The Heart Failure Drugs market ... Read More
Research Assistance
